MedTech News
.................... by Andrew Celentano
Researchers develop light-activated drugs that restore sight in blind mice
Blinding diseases caused by the degeneration of photoreceptors, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), affect 200 million people worldwide and represent the leading causes of visual impairment and blindness.
New machine-learning equation accurately assess LDL cholesterol risk
The Martin-Hopkins equation to assess low-density lipoprotein (LDL) cholesterol levels in blood samples has been used by laboratories in the U.S. and other countries to guide efforts to lower cardiovascular disease risk. Now, a simplified machine-learning version of this equation has been shown in a study of millions of U.S. adult and child blood samples to match the accuracy of the original—making it broadly accessible.
AI flags heart failure risk five years early from routine ECG recordings
Researchers at the Technion Faculty of Biomedical Engineering have achieved a breakthrough in the early detection of heart failure.
Bile acid buildup drives spread of breast cancer, discovery reveals
A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, new University of Virginia Comprehensive Cancer Center research reveals. The findings could open the door to new ways to prevent breast cancer metastasis (spread), improve patient outcomes and save lives.
The invisible wearable: New skin sensors advance health monitoring
While wearable health sensors are becoming increasingly common, current iterations are awkward to wear. For example, devices attached to the face can draw unwanted attention, increase self-consciousness and influence the signals users are trying to measure. However, recent research may have found a solution by introducing ultrathin sensors that cannot be seen by observers or felt by the wearer.
New tool makes immune therapy more effective in prostate cancer
Prostate cancer is often resistant to immunotherapy, which harnesses a person’s immune system to recognize and destroy tumors. But a new technology that targets RNA in cancer cells gave immunotherapy new life, improving its ability to unleash cancer-killing cells in laboratory studies.
ElectroWire Medical Receives 510(k) Clearance for LightningWire™ Transseptal Puncture System
LEXINGTON, S.C., July 15, 2026 /PRNewswire/ — ElectroWire Medical announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its LightningWireTM Transseptal Puncture System, which is indicated to create an atrial septal defect in the heart, whereby various cardiovascular catheters are introduced.
SpinaFX Medical Receives CE Mark MDR Certification for its Triojection® System
TORONTO, July 15, 2026 /PRNewswire/ — SpinaFX Medical Inc. (“SpinaFX”), a Toronto‑based medical device company specializing in image‑guided, minimally invasive spine care, today announced it has received Medical Device Regulation (MDR) CE Mark certification for its Triojection® System (MDR 843778).